(-0.07%) 5 304.50 points
(-0.02%) 40 134 points
(-0.11%) 18 484 points
(0.77%) $81.98
(-1.75%) $1.688
(0.28%) $2 218.80
(-0.64%) $24.59
(-0.01%) $909.60
(0.46%) $0.928
(0.69%) $10.84
(0.28%) $0.793
(-0.15%) $92.31
@ $32.43
Issued: 14 Feb 2024 @ 09:32
Return: 26.15%
Previous signal: Feb 13 - 09:30
Previous signal:
Return: -1.90 %
Live Chart Being Loaded With Signals
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment...
Stats | |
---|---|
Today's Volume | 349 937 |
Average Volume | 450 803 |
Market Cap | 1.31B |
EPS | $0 ( 2024-02-22 ) |
Next earnings date | ( $1.500 ) 2024-05-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 31.71 |
ATR14 | $0.0280 (0.07%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-29 | Smith Thomas B | Sell | 995 | Common Stock |
2024-02-26 | Dreyer Scott | Sell | 9 336 | Common Stock |
2024-02-26 | Dreyer Scott | Sell | 664 | Common Stock |
2024-02-12 | Tupper Colleen | Buy | 30 856 | Common Stock |
2024-02-12 | Tupper Colleen | Sell | 16 868 | Common Stock |
INSIDER POWER |
---|
14.73 |
Last 100 transactions |
Buy: 1 331 449 | Sell: 1 023 987 |
Volume Correlation
Collegium Pharmaceutical Correlation
10 Most Positive Correlations | |
---|---|
BNIXU | 0.971 |
AHCO | 0.934 |
MDRX | 0.929 |
CARA | 0.928 |
RKDA | 0.927 |
ATRA | 0.925 |
CSSE | 0.925 |
DISH | 0.924 |
ETSY | 0.923 |
UPLD | 0.922 |
10 Most Negative Correlations | |
---|---|
MSDA | -0.922 |
MTEK | -0.914 |
BRIVU | -0.911 |
VLAT | -0.91 |
TIOAU | -0.909 |
ADAL | -0.908 |
PPYAU | -0.906 |
NVCN | -0.902 |
BNIX | -0.902 |
BRIV | -0.899 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Collegium Pharmaceutical Correlation - Currency/Commodity
Collegium Pharmaceutical Financials
Annual | 2023 |
Revenue: | $566.77M |
Gross Profit: | $326.17M (57.55 %) |
EPS: | $1.430 |
Q4 | 2023 |
Revenue: | $149.75M |
Gross Profit: | $94.63M (63.19 %) |
EPS: | $0.950 |
Q3 | 2023 |
Revenue: | $136.71M |
Gross Profit: | $80.31M (58.75 %) |
EPS: | $0.610 |
Q2 | 2023 |
Revenue: | $135.55M |
Gross Profit: | $73.83M (54.47 %) |
EPS: | $0.380 |
Financial Reports:
No articles found.
Collegium Pharmaceutical
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators